My Top 3 Biotech Stocks for May 2026
Source: Motley Fool
2026-05-20 11:35:00 ET
Biotech investors are finally getting something they haven't seen in years: a friendlier macro environment. Interest rates appear to be stabilizing, FDA activity is picking up again, and large pharmaceutical companies are sitting on billions in cash while staring down looming patent cliffs.
That combination is creating a fertile backdrop for smaller biotech companies with strong pipelines, differentiated technology, and upcoming catalysts. Here are my top three biotech stocks for May.
Image source: Getty Images.
Schrodinger Inc.
NASDAQ: SDGR
SDGR Trading
-8.84% G/L:
$14.61 Last:
639,042 Volume:
$15.85 Open:
SDGR Latest News
June 02, 2026 05:32:15 pm
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
SDGR Stock Data
$1,004,786,549
66,519,227
0.03%
83
N/A
Healthcare Providers & Services
Healthcare
US
New York
